Arrowhead Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2019
Total Assets: $349.8M
Liabilities Breakdown FY2019
Total Liabilities: $105.3M
Asset Breakdown
Total Assets: $349.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $221.8M | 63.4% |
| Accounts Receivable | $661.4K | 0.2% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $23.2M | 6.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $17.1M | 4.9% |
| Other Assets | $87.1M | 24.9% |
Liabilities Breakdown
Total Liabilities: $105.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $7.6M | 7.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $97.6M | 92.7% |